{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:46Z","timestamp":1786119406802,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/md.0000000000003788","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T11:07:09Z","timestamp":1464260829000},"page":"e3788","source":"Crossref","is-referenced-by-count":18,"title":["Integration of Chinese Herbal Medicine Therapy Improves Survival of Patients With Chronic Lymphocytic Leukemia"],"prefix":"10.1097","volume":"95","author":[{"given":"Tom","family":"Fleischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Ti","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Huai","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Rong","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-46-20210226","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM199510193331606","article-title":"Chronic lymphocytic leukemia","volume":"333","author":"Rozman","year":"1995","journal-title":"N Engl J Med"},{"key":"R2-46-20210226","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","article-title":"Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial","volume":"376","author":"Hallek","year":"2010","journal-title":"Lancet"},{"key":"R3-46-20210226","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1400376","article-title":"Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia","volume":"371","author":"Byrd","year":"2014","journal-title":"N Engl J Med"},{"key":"R4-46-20210226","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","article-title":"Idelalisib and rituximab in relapsed chronic lymphocytic leukemia","volume":"370","author":"Furman","year":"2014","journal-title":"N Engl J Med"},{"key":"R5-46-20210226","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1470-2045(13)70513-8","article-title":"Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b\/2 trial","volume":"15","author":"O\u2019Brien","year":"2014","journal-title":"Lancet Oncol"},{"key":"R6-46-20210226","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(14)70335-3","article-title":"Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study","volume":"15","author":"Burger","year":"2014","journal-title":"Lancet Oncol"},{"key":"R7-46-20210226","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N Engl J Med"},{"key":"R8-46-20210226","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat Med"},{"key":"R9-46-20210226","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0145-2126(03)00009-2","article-title":"Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysis","volume":"27","author":"Battle","year":"2003","journal-title":"Leukemia Res"},{"key":"R10-46-20210226","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1158\/1078-0432.CCR-08-1511","article-title":"Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG","volume":"15","author":"Ghosh","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R11-46-20210226","first-page":"633","article-title":"Extract of Hedyotis diffusa Willd influences murine leukemia WEHI-3 cells in vivo as well as promoting T- and B-cell proliferation in leukemic mice","volume":"25","author":"Lin","year":"2011","journal-title":"In Vivo"},{"key":"R12-46-20210226","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1073\/pnas.0409467102","article-title":"Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells","volume":"102","author":"Nam","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R13-46-20210226","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jcb.24946","article-title":"Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid","volume":"116","author":"Radwan","year":"2015","journal-title":"J Cell Biochem"},{"key":"R14-46-20210226","doi-asserted-by":"crossref","first-page":"751046","DOI":"10.1155\/2012\/751046","article-title":"Traditional Chinese medicine in cancer care: a review of case series published in the Chinese literature","volume":"2012","author":"Yang","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"R15-46-20210226","doi-asserted-by":"crossref","first-page":"740515","DOI":"10.1155\/2014\/740515","article-title":"Introduction to the history and current status of evidence-based korean medicine: a unique integrated system of allopathic and holistic medicine","volume":"2014","author":"Yin","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"R16-46-20210226","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ctim.2014.04.002","article-title":"A nationwide population-based study of traditional Chinese medicine usage in children in Taiwan","volume":"22","author":"Huang","year":"2014","journal-title":"Complement Ther Med"},{"key":"R17-46-20210226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1472-6963-7-26","article-title":"Use frequency of traditional Chinese medicine in Taiwan","volume":"7","author":"Chen","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"R19-46-20210226","doi-asserted-by":"crossref","first-page":"e2536","DOI":"10.1097\/MD.0000000000002536","article-title":"Association of traditional Chinese medicine therapy and the risk of vascular complications in patients with type II diabetes mellitus: a nationwide, retrospective, Taiwanese-registry, cohort study","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine"},{"key":"R20-46-20210226","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jep.2016.04.018","article-title":"Characteristics of traditional Chinese medicine usage in patients with stroke in Taiwan: a nationwide population-based study","volume":"186","author":"Chang","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"R21-46-20210226","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cam4.627","article-title":"Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population-based cohort study","volume":"5","author":"Fleischer","year":"2016","journal-title":"Cancer Med"},{"key":"R22-46-20210226","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jep.2015.10.024","article-title":"Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: a nationwide population-based study","volume":"176","author":"Huang","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"R23-46-20210226","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/blood-2010-05-285221","article-title":"The incidence of chronic lymphocytic leukemia in Taiwan, 1986\u20132005: a distinct increasing trend with birth-cohort effect","volume":"116","author":"Wu","year":"2010","journal-title":"Blood"},{"key":"R24-46-20210226","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/10428194.2013.803223","article-title":"Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey","volume":"55","author":"D\u2019Arena","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"R25-46-20210226","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00520-008-0452-y","article-title":"Complementary and alternative medicine in patients with chronic lymphocytic leukemia","volume":"17","author":"Hensel","year":"2009","journal-title":"Support Care Cancer"},{"key":"R26-46-20210226","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1055\/s-2008-1081505","article-title":"The use of complementary alternative medicine (CAM) in 1 001 German adults: results of a population-based telephone survey","volume":"70","author":"Bucker","year":"2008","journal-title":"Gesundheitswesen"},{"key":"R27-46-20210226","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7861\/clinmedicine.12-6-505","article-title":"Prevalence of use of complementary and alternative medicine (CAM) by physicians in the UK: a systematic review of surveys","volume":"12","author":"Posadzki","year":"2012","journal-title":"Clin Med"},{"key":"R28-46-20210226","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/asheducation-2013.1.158","article-title":"Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers","volume":"2013","author":"Shanafelt","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R30-46-20210226","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10428190701724785","article-title":"Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia","volume":"49","author":"Thurmes","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"R31-46-20210226","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3324\/haematol.2013.096792","article-title":"Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials","volume":"99","author":"Goede","year":"2014","journal-title":"Haematologica"},{"key":"R32-46-20210226","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3109\/10428194.2014.898758","article-title":"The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive surveillance, epidemiology, and end results analysis in the modern era","volume":"55","author":"Nabhan","year":"2014","journal-title":"Leuk lymphoma"},{"key":"R33-46-20210226","doi-asserted-by":"crossref","first-page":"e62930","DOI":"10.1371\/journal.pone.0062930","article-title":"Improving but inferior survival in patients with chronic lymphocytic leukemia in Taiwan: a population-based study, 1990\u20132004","volume":"8","author":"Wu","year":"2013","journal-title":"PloS One"},{"key":"R34-46-20210226","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2008.07226.x","article-title":"South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients","volume":"142","author":"Gunawardana","year":"2008","journal-title":"Brit J Haematol"},{"key":"R35-46-20210226","first-page":"1","article-title":"Plasticity of health","volume":"1","author":"Leischik","year":"2016","journal-title":"German J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000003788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:10:13Z","timestamp":1786039813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201605240-00046"}},"subtitle":["A Nationwide Population-Based Cohort Study"],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":33,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003788","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}